June Sherie Almenoff is President at Furiex Pharmaceuticals, Inc. (FURX). They have made 11 open-market trades across 6 companies since 2011, most recently 2026-09-02.
CIK 0001492647
11 open-market purchases totalling $281K since 2011, never a sale. Across 7 scored buys the stock is down 1.0% at ninety days, and 2.7 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 43% | 86% | 71% |
| Avg Move | -13.4% | +11.5% | -1.0% |
| Alpha | -12.2% | +9.6% | -2.7% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TENX | BUY | 2025-11-17 | 2025-11-20 | $7.50 | $15K | +18.0% | +59.9% | +60.5% |
| AVTX | BUY | 2024-11-12 | 2024-11-14 | $12.75 | $13K | -26.0% | -30.2% | -43.1% |
| BCLI | BUY | 2019-01-04 | 2019-01-08 | $3.39 | $5K | +0.6% | +11.6% | +20.6% |
| INNT | BUY | 2018-08-24 | 2018-08-28 | $4.92 | $7K | +20.8% | +37.0% | -47.4% |
| OHRP | BUY | 2015-02-06 | 2015-02-10 | $6.75 | $41K | -35.8% | +0.8% | +0.8% |
| OHRP | BUY | 2014-06-26 | 2014-06-30 | $8.34 | $27K | -35.8% | +0.8% | +0.8% |
| OHRP | BUY | 2014-04-08 | 2014-04-09 | $10.25 | $56K | -35.8% | +0.8% | +0.8% |
| FURX | SELL · 10b5-1 | 2014-02-04 | 2014-02-06 | $115.29 | $13.3M | N/A | N/A | N/A |
| FURX | BUY | 2012-08-14 | 2012-08-16 | $18.67 | $19K | N/A | N/A | N/A |
| FURX | BUY | 2012-05-17 | 2012-05-18 | $14.80 | $30K | N/A | N/A | N/A |
| FURX | BUY | 2012-02-24 | 2012-02-28 | $18.21 | $55K | N/A | N/A | N/A |
| FURX | BUY | 2011-09-09 | 2011-09-13 | $14.95 | $15K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total |
| $150K |
Shares reported on the most recent Form 4, priced at the 2026-09-04 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.